Safety and Effectiveness of Ixazomib Dose-escalating Strategy in Ixazomib-Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma

Background/Aim: Gastrointestinal toxicity is common in patients receiving common therapy of ixazomib with lenalidomide and low-dose dexamethasone (IRd) for relapsed/refractory multiple myeloma. Here, we investigated the safety and effectiveness of ixazomib dosing schedules. Patients and Methods: We...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:In Vivo
Main Authors: OHASHI, YASUKATA, YATABE, MEGUMI, NIIJIMA, DAISUKE, TANI, KENTARO, OGAWA, CHIAKI, YACHI, YUTAKA, KAGOO, TOSHIYA, BOKU, SAIGEN, UENO, HIRONORI, YANO, TAKAHIRO, HIGAI, KOJI, YOKOYAMA, AKIHIRO
Formato: Artigo
Idioma:Inglês
Publicado em: International Institute of Anticancer Research 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7652488/
https://ncbi.nlm.nih.gov/pubmed/32871820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12108
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados